サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：補助人工心臓市場 - 成長、将来の見通し、競合分析（2022年～2030年）
市場調査レポート
商品コード
1192939

補助人工心臓市場 - 成長、将来の見通し、競合分析（2022年～2030年）

Ventricular Assist Devices Market - Growth, Future Prospects and Competitive Analysis, 2022 - 2030
出版日: | 発行: Acute Market Reports | ページ情報: 英文 118 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.53円
補助人工心臓市場 - 成長、将来の見通し、競合分析（2022年～2030年）
出版日: 2022年08月19日
発行: Acute Market Reports
ページ情報: 英文 118 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の補助人工心臓市場は、心筋症、糖尿病、脳卒中などの生活習慣病の増加や、高い有効性、良好な患者への適合性、低いコストで利用できることにより、成長が加速しています。

当レポートでは、世界の補助人工心臓市場について調査分析し、市場力学、セグメント分析、地域分析、企業プロファイルなどを提供しています。

目次

第1章 序文

第2章 エグゼクティブサマリー

第3章 補助人工心臓市場：競合分析

  • 主な補助人工心臓市場ベンダーの市場ポジショニング
  • 補助人工心臓市場ベンダーが採用する戦略
  • 主な業界戦略
  • 階層分析（2021年 vs. 2030年）

第4章 補助人工心臓市場：マクロ分析と市場力学

  • イントロダクション
  • 世界の補助人工心臓の市場金額（2020年～2030年）
  • 市場力学
    • 市場促進要因
    • 市場抑制要因
    • 主な課題
    • 主な機会
  • 促進要因と抑制要因の影響の分析
  • シーソー分析

第5章 補助人工心臓市場：タイプ別（2020年～2030年）

  • 市場の概要
  • 成長と収益の分析：（2021年 vs. 2030年）
  • 市場セグメンテーション
    • 右室補助人工心臓
    • 左室補助人工心臓
    • 両室補助人工心臓

第6章 補助人工心臓市場：用途別（2020年～2030年）

  • 市場の概要
  • 成長と収益の分析：（2021年 vs. 2030年）
  • 市場セグメンテーション
    • BTT（Bridge to Transplant）
    • BTD（Bridge to Destination）
    • BTR（Bridge to Recovery）

第7章 北米の補助人工心臓市場（2020年～2030年）

  • 市場の概要
  • 補助人工心臓市場：タイプ別（2020年～2030年）
  • 補助人工心臓市場：用途別（2020年～2030年）
  • 補助人工心臓市場：地域別（2020年～2030年）
    • 北米

第8章 英国・欧州連合の補助人工心臓市場（2020年～2030年）

  • 市場の概要
  • 補助人工心臓市場：タイプ別（2020年～2030年）
  • 補助人工心臓市場：用途別（2020年～2030年）
  • 補助人工心臓市場：地域別（2020年～2030年）
    • 英国・欧州連合

第9章 アジア太平洋の補助人工心臓市場（2020年～2030年）

  • 市場の概要
  • 補助人工心臓市場：タイプ別（2020年～2030年）
  • 補助人工心臓市場：用途別（2020年～2030年）
  • 補助人工心臓市場：地域別（2020年～2030年）
    • アジア太平洋

第10章 ラテンアメリカの補助人工心臓市場（2020年～2030年）

  • 市場の概要
  • 補助人工心臓市場：タイプ別（2020年～2030年）
  • 補助人工心臓市場：用途別（2020年～2030年）
  • 補助人工心臓市場：地域別（2020年～2030年）
    • ラテンアメリカ

第11章 中東・アフリカの補助人工心臓市場（2020年～2030年）

  • 市場の概要
  • 補助人工心臓市場：タイプ別（2020年～2030年）
  • 補助人工心臓市場：用途別（2020年～2030年）
  • 補助人工心臓市場：地域別（2020年～2030年）
    • 中東・アフリカ

第12章 企業プロファイル

  • Abiomed
  • Berlin Heart GmbH
  • Cardiac Assist, Inc.
  • HeartWare International, Inc.
  • Jarvik Heart, Inc.
  • Reliant Heart, Inc.
  • St. Jude Medical, LLC.
  • Sun Medical Technology Research Corp.
  • Syncardia System, Inc.
  • Thoratec Corporation
図表

List of Tables

  • TABLE 1 Global Ventricular Assist Devices Market By Type, 2020-2030, USD (Million)
  • TABLE 2 Global Ventricular Assist Devices Market By Application, 2020-2030, USD (Million)
  • TABLE 3 North America Ventricular Assist Devices Market By Type, 2020-2030, USD (Million)
  • TABLE 4 North America Ventricular Assist Devices Market By Application, 2020-2030, USD (Million)
  • TABLE 5 U.S. Ventricular Assist Devices Market By Type, 2020-2030, USD (Million)
  • TABLE 6 U.S. Ventricular Assist Devices Market By Application, 2020-2030, USD (Million)
  • TABLE 7 Canada Ventricular Assist Devices Market By Type, 2020-2030, USD (Million)
  • TABLE 8 Canada Ventricular Assist Devices Market By Application, 2020-2030, USD (Million)
  • TABLE 9 Rest of North America Ventricular Assist Devices Market By Type, 2020-2030, USD (Million)
  • TABLE 10 Rest of North America Ventricular Assist Devices Market By Application, 2020-2030, USD (Million)
  • TABLE 11 UK and European Union Ventricular Assist Devices Market By Type, 2020-2030, USD (Million)
  • TABLE 12 UK and European Union Ventricular Assist Devices Market By Application, 2020-2030, USD (Million)
  • TABLE 13 UK Ventricular Assist Devices Market By Type, 2020-2030, USD (Million)
  • TABLE 14 UK Ventricular Assist Devices Market By Application, 2020-2030, USD (Million)
  • TABLE 15 Germany Ventricular Assist Devices Market By Type, 2020-2030, USD (Million)
  • TABLE 16 Germany Ventricular Assist Devices Market By Application, 2020-2030, USD (Million)
  • TABLE 17 Spain Ventricular Assist Devices Market By Type, 2020-2030, USD (Million)
  • TABLE 18 Spain Ventricular Assist Devices Market By Application, 2020-2030, USD (Million)
  • TABLE 19 Italy Ventricular Assist Devices Market By Type, 2020-2030, USD (Million)
  • TABLE 20 Italy Ventricular Assist Devices Market By Application, 2020-2030, USD (Million)
  • TABLE 21 France Ventricular Assist Devices Market By Type, 2020-2030, USD (Million)
  • TABLE 22 France Ventricular Assist Devices Market By Application, 2020-2030, USD (Million)
  • TABLE 23 Rest of Europe Ventricular Assist Devices Market By Type, 2020-2030, USD (Million)
  • TABLE 24 Rest of Europe Ventricular Assist Devices Market By Application, 2020-2030, USD (Million)
  • TABLE 25 Asia Ventricular Assist Devices Market By Type, 2020-2030, USD (Million)
  • TABLE 26 Asia Ventricular Assist Devices Market By Application, 2020-2030, USD (Million)
  • TABLE 27 China Ventricular Assist Devices Market By Type, 2020-2030, USD (Million)
  • TABLE 28 China Ventricular Assist Devices Market By Application, 2020-2030, USD (Million)
  • TABLE 29 Japan Ventricular Assist Devices Market By Type, 2020-2030, USD (Million)
  • TABLE 30 Japan Ventricular Assist Devices Market By Application, 2020-2030, USD (Million)
  • TABLE 31 India Ventricular Assist Devices Market By Type, 2020-2030, USD (Million)
  • TABLE 32 India Ventricular Assist Devices Market By Application, 2020-2030, USD (Million)
  • TABLE 33 Australia Ventricular Assist Devices Market By Type, 2020-2030, USD (Million)
  • TABLE 34 Australia Ventricular Assist Devices Market By Application, 2020-2030, USD (Million)
  • TABLE 35 South Korea Ventricular Assist Devices Market By Type, 2020-2030, USD (Million)
  • TABLE 36 South Korea Ventricular Assist Devices Market By Application, 2020-2030, USD (Million)
  • TABLE 37 Latin America Ventricular Assist Devices Market By Type, 2020-2030, USD (Million)
  • TABLE 38 Latin America Ventricular Assist Devices Market By Application, 2020-2030, USD (Million)
  • TABLE 39 Brazil Ventricular Assist Devices Market By Type, 2020-2030, USD (Million)
  • TABLE 40 Brazil Ventricular Assist Devices Market By Application, 2020-2030, USD (Million)
  • TABLE 41 Mexico Ventricular Assist Devices Market By Type, 2020-2030, USD (Million)
  • TABLE 42 Mexico Ventricular Assist Devices Market By Application, 2020-2030, USD (Million)
  • TABLE 43 Rest of Latin America Ventricular Assist Devices Market By Type, 2020-2030, USD (Million)
  • TABLE 44 Rest of Latin America Ventricular Assist Devices Market By Application, 2020-2030, USD (Million)
  • TABLE 45 Middle East and Africa Ventricular Assist Devices Market By Type, 2020-2030, USD (Million)
  • TABLE 46 Middle East and Africa Ventricular Assist Devices Market By Application, 2020-2030, USD (Million)
  • TABLE 47 GCC Ventricular Assist Devices Market By Type, 2020-2030, USD (Million)
  • TABLE 48 GCC Ventricular Assist Devices Market By Application, 2020-2030, USD (Million)
  • TABLE 49 Africa Ventricular Assist Devices Market By Type, 2020-2030, USD (Million)
  • TABLE 50 Africa Ventricular Assist Devices Market By Application, 2020-2030, USD (Million)
  • TABLE 51 Rest of Middle East and Africa Ventricular Assist Devices Market By Type, 2020-2030, USD (Million)
  • TABLE 52 Rest of Middle East and Africa Ventricular Assist Devices Market By Application, 2020-2030, USD (Million)

List of Figures

  • FIG. 1 Global Ventricular Assist Devices Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Ventricular Assist Devices Market: Quality Assurance
  • FIG. 5 Global Ventricular Assist Devices Market, By Type, 2021
  • FIG. 6 Global Ventricular Assist Devices Market, By Application, 2021
  • FIG. 7 Global Ventricular Assist Devices Market, By Geography, 2021
  • FIG. 8 Market Geographical Opportunity Matrix - Global Ventricular Assist Devices Market, 2021
  • FIG. 9 Market Positioning of Key Ventricular Assist Devices Market Players, 2021
  • FIG. 10 Global Ventricular Assist Devices Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
  • FIG. 11 Global Ventricular Assist Devices Market, By Type, 2021 Vs 2030, %
  • FIG. 12 Global Ventricular Assist Devices Market, By Application, 2021 Vs 2030, %
  • FIG. 13 U.S. Ventricular Assist Devices Market (US$ Million), 2020 - 2030
  • FIG. 14 Canada Ventricular Assist Devices Market (US$ Million), 2020 - 2030
  • FIG. 15 Rest of North America Ventricular Assist Devices Market (US$ Million), 2020 - 2030
  • FIG. 16 UK Ventricular Assist Devices Market (US$ Million), 2020 - 2030
  • FIG. 17 Germany Ventricular Assist Devices Market (US$ Million), 2020 - 2030
  • FIG. 18 Spain Ventricular Assist Devices Market (US$ Million), 2020 - 2030
  • FIG. 19 Italy Ventricular Assist Devices Market (US$ Million), 2020 - 2030
  • FIG. 20 France Ventricular Assist Devices Market (US$ Million), 2020 - 2030
  • FIG. 21 Rest of Europe Ventricular Assist Devices Market (US$ Million), 2020 - 2030
  • FIG. 22 China Ventricular Assist Devices Market (US$ Million), 2020 - 2030
  • FIG. 23 Japan Ventricular Assist Devices Market (US$ Million), 2020 - 2030
  • FIG. 24 India Ventricular Assist Devices Market (US$ Million), 2020 - 2030
  • FIG. 25 Australia Ventricular Assist Devices Market (US$ Million), 2020 - 2030
  • FIG. 26 South Korea Ventricular Assist Devices Market (US$ Million), 2020 - 2030
  • FIG. 27 Rest of Asia Ventricular Assist Devices Market (US$ Million), 2020 - 2030
  • FIG. 28 Brazil Ventricular Assist Devices Market (US$ Million), 2020 - 2030
  • FIG. 29 Mexico Ventricular Assist Devices Market (US$ Million), 2020 - 2030
  • FIG. 30 Rest of Latin America Ventricular Assist Devices Market (US$ Million), 2020 - 2030
  • FIG. 31 GCC Ventricular Assist Devices Market (US$ Million), 2020 - 2030
  • FIG. 32 Africa Ventricular Assist Devices Market (US$ Million), 2020 - 2030
  • FIG. 33 Rest of Middle East and Africa Ventricular Assist Devices Market (US$ Million), 2020 - 2030
目次
Product Code: 137595-08-22

Congestive heart failure is a potential life-threatening condition that weakens the heart muscles and reduces the ability to pump blood through the body. Patients' life can be extended and improved with the use of ventricular assist devices as it is an effective alternative for heart transplant. Ventricular assist devices are mechanical instruments that improves the pumping of blood and maintain efficient flow throughout the body. Rising number of geriatric population with cardiac complication, lifestyle change with increasing consumption of junk food, binge drinking and drug abuse are responsible for the rise in lifestyle diseases like cardiovascular, diabetes and stroke. Increasing number cardiovascular surgical procedures will result into deep market penetration of the ventricular assist devices.

For the purpose of this study, the various types studied include left ventricular assist device, right ventricular assist device and bi-ventricular assist device. The ventricular assist devices applications are further categorized as bridge to transplant, bridge to destination and bridge to recovery.

This report also includes qualitative assessment factors such as market dynamics (drivers, restraints and opportunities) to have a good understanding of the current and anticipated trends in the global ventricular assist devices market. Competition assessment tools such as Porter's five forces analysis, market attractiveness assessment and competitive landscape analysis by key players are also presented in the study. Furthermore, this report concludes with profiling of key market players currently enjoying prominent position in the global ventricular assist devices market. The key players profiled in this report are Abiomed, Berlin Heart GmbH, Cardiac Assist, Inc., HeartWare International, Inc., Jarvik Heart, Inc., Reliant Heart, Inc., St. Jude Medical, LLC., Sun Medical Technology Research Corp., Syncardia System Inc. and Thoratec Corporation.

Ventricular assist device is a mechanical pump which takes blood from a lower chamber of heart and pumps it to the body and vital organs. They are used for short duration in patients recovering from myocardial infarction or cardiac surgery, whereas long term use is for patients suffering from total heart failure and patients suffering class III & class IV heart failure waiting for a heart transplant. Rise in lifestyle diseases like cardiomyopathy, diabetes and stroke, higher efficacy, better patient suitability and easy availability at low cost is fuelling the ventricular assist devices market growth.

In 2021, left ventricular assist devices held the largest market share due to rising number of patients suffering with left ventricular damage i.e. cardiomyopathy, and reduction in the number of heart donors. Right ventricular assist devices segment is anticipated to register faster growth throughout the forecast period 2022-2030, majorly due to increasing number of patients suffering with congestive heart failure and pulmonary hypertension. Overall, the global ventricular assist devices market is highly competitive with presence of multiple players like Thoratec, Abiomed, St. Jude Medical, LLC., Reliant Heart Inc., HeartWare International, Inc., SynCardia System Inc., etc. specializing in respective fields. Technological advancement in the device design, raw material and manufacturing has been significant from the first generation devices containing pulsatile volume displacement pumps powered by pneumatic or electrical drive system, which were later replaced with the second generation continuous flow pumps.

According to the European Society of Cardiology (ESC), 17%-45% of heart failure patients admitted in hospitals worldwide die within 1 year of admission. The British Heart Foundation (BHF) claims that the causative agent for heart failure are heart valve problems, abuse of alcohol or recreational drugs, arrhythmia, congenital heart disease, viral infection of the heart muscles etc. In 2021, bridge to transplant segment dominated the application market significantly due to factors such as rising prevalence of congestive heart failure and increasing number of patients which showed failure in optimal medical management and are at risk of imminent death and require immediate heart transplantation. Bridge to destination segment will be the fastest growing segment in the application market throughout the forecast period 2022-2030, majorly due to factors such as large number of patients are deemed too old for a heart transplant, compromised immunity, left ventricular ejection fraction less than 25% and can survive with a LVAD throughout their lifespan. Bridge to recovery offers a lucrative market opportunity as it is finding huge application in patients with temporary heart failure, patients recovering from heart surgery get VAD implanted until the heart is strong enough to pump blood.

North America was observed to be the largest market for ventricular assist devices in the base year 2021. According to the Centers for Disease Control and Prevention about 610,000 Americans die each year due to heart disease, which represents 1 in every 4 deaths. The dominance of North America is mainly attributed to rise in lifestyle diseases such as cardiovascular disease, stroke, and chronic pulmonary hypertension, shift in lifestyle with increased drug abuse, binge drinking, and consumption of fast food and evolved reimbursement scenario favoring ventricular assist devices use. According to the European Cardiovascular Disease Statistics - 2022, each year CVD causes 3.9 million deaths in Europe and 1.8 million deaths in the European Union. The market growth in Europe is chiefly attributed to increasing number of patients suffering with cardiovascular complications, and supportive regulatory approval for ventricular assist devices market.

Asia Pacific will be the fastest-growing regional segment throughout the forecast period 2022-2030. Factors that propel the market growth are rising prevalence of geriatric population suffering from cardiac complication, increasing healthcare expenditure in these regions, and increasing disposable incomes. Factors such as developing health infrastructure, increasing awareness, and increasing demand for ventricular assist devices are going to fuel the rapid growth of ventricular assist devices market in Latin America, and Middle East and Africa region in the near future.

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Ventricular Assist Devices market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Ventricular Assist Devices market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Type

Right Ventricular Assist Devices

Left Ventricular Assist Devices

Bi-Ventricular Assist Devices

Application

Bridge to Transplant (BTT)

Bridge to Destination (BTD)

Bridge to Recovery (BTR)

Region Segment (2020-2030; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

UK

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Global Impact of Covid-19 Segment (2020-2021; US$ Million )

Pre Covid-19 situation

Post Covid-19 situation

Key questions answered in this report

What are the key micro and macro environmental factors that are impacting the growth of Ventricular Assist Devices market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2030.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Ventricular Assist Devices market?

Which is the largest regional market for Ventricular Assist Devices market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Ventricular Assist Devices market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Ventricular Assist Devices market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Ventricular Assist Devices Market
  • 2.2. Global Ventricular Assist Devices Market, By Type, 2021 (US$ Million)
  • 2.3. Global Ventricular Assist Devices Market, By Application, 2021 (US$ Million)
  • 2.4. Global Ventricular Assist Devices Market, By Geography, 2021 (US$ Million)
  • 2.5. Attractive Investment Proposition by Geography, 2021

3. Ventricular Assist Devices Market: Competitive Analysis

  • 3.1. Market Positioning of Key Ventricular Assist Devices Market Vendors
  • 3.2. Strategies Adopted by Ventricular Assist Devices Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2021 Versus 2030

4. Ventricular Assist Devices Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Ventricular Assist Devices Market Value, 2020 - 2030, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Ventricular Assist Devices Market: By Type, 2020-2030, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 5.3. Market Segmentation
    • 5.3.1. Right Ventricular Assist Devices
    • 5.3.2. Left Ventricular Assist Devices
    • 5.3.3. Bi-Ventricular Assist Devices

6. Ventricular Assist Devices Market: By Application, 2020-2030, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 6.3. Market Segmentation
    • 6.3.1. Bridge to Transplant (BTT)
    • 6.3.2. Bridge to Destination (BTD)
    • 6.3.3. Bridge to Recovery (BTR)

7. North America Ventricular Assist Devices Market, 2020-2030, USD (Million)

  • 7.1. Market Overview
  • 7.2. Ventricular Assist Devices Market: By Type, 2020-2030, USD (Million)
  • 7.3. Ventricular Assist Devices Market: By Application, 2020-2030, USD (Million)
  • 7.4.Ventricular Assist Devices Market: By Region, 2020-2030, USD (Million)
    • 7.4.1.North America
      • 7.4.1.1. U.S.
        • 7.4.1.1.1. Ventricular Assist Devices Market: By Type, 2020-2030, USD (Million)
        • 7.4.1.1.1. Ventricular Assist Devices Market: By Application, 2020-2030, USD (Million)
      • 7.4.1.2. Canada
        • 7.4.1.2.1. Ventricular Assist Devices Market: By Type, 2020-2030, USD (Million)
        • 7.4.1.2.1. Ventricular Assist Devices Market: By Application, 2020-2030, USD (Million)
      • 7.4.1.3. Rest of North America
        • 7.4.1.3.1. Ventricular Assist Devices Market: By Type, 2020-2030, USD (Million)
        • 7.4.1.3.1. Ventricular Assist Devices Market: By Application, 2020-2030, USD (Million)

8. UK and European Union Ventricular Assist Devices Market, 2020-2030, USD (Million)

  • 8.1. Market Overview
  • 8.2. Ventricular Assist Devices Market: By Type, 2020-2030, USD (Million)
  • 8.3. Ventricular Assist Devices Market: By Application, 2020-2030, USD (Million)
  • 8.4.Ventricular Assist Devices Market: By Region, 2020-2030, USD (Million)
    • 8.4.1.UK and European Union
      • 8.4.1.1. UK
        • 8.4.1.1.1. Ventricular Assist Devices Market: By Type, 2020-2030, USD (Million)
        • 8.4.1.1.1. Ventricular Assist Devices Market: By Application, 2020-2030, USD (Million)
      • 8.4.1.2. Germany
        • 8.4.1.2.1. Ventricular Assist Devices Market: By Type, 2020-2030, USD (Million)
        • 8.4.1.2.1. Ventricular Assist Devices Market: By Application, 2020-2030, USD (Million)
      • 8.4.1.3. Spain
        • 8.4.1.3.1. Ventricular Assist Devices Market: By Type, 2020-2030, USD (Million)
        • 8.4.1.3.1. Ventricular Assist Devices Market: By Application, 2020-2030, USD (Million)
      • 8.4.1.4. Italy
        • 8.4.1.4.1. Ventricular Assist Devices Market: By Type, 2020-2030, USD (Million)
        • 8.4.1.4.1. Ventricular Assist Devices Market: By Application, 2020-2030, USD (Million)
      • 8.4.1.5. France
        • 8.4.1.5.1. Ventricular Assist Devices Market: By Type, 2020-2030, USD (Million)
        • 8.4.1.5.1. Ventricular Assist Devices Market: By Application, 2020-2030, USD (Million)
      • 8.4.1.6. Rest of Europe
        • 8.4.1.6.1. Ventricular Assist Devices Market: By Type, 2020-2030, USD (Million)
        • 8.4.1.6.1. Ventricular Assist Devices Market: By Application, 2020-2030, USD (Million)

9. Asia Pacific Ventricular Assist Devices Market, 2020-2030, USD (Million)

  • 9.1. Market Overview
  • 9.2. Ventricular Assist Devices Market: By Type, 2020-2030, USD (Million)
  • 9.3. Ventricular Assist Devices Market: By Application, 2020-2030, USD (Million)
  • 9.4.Ventricular Assist Devices Market: By Region, 2020-2030, USD (Million)
    • 9.4.1.Asia Pacific
      • 9.4.1.1. China
        • 9.4.1.1.1. Ventricular Assist Devices Market: By Type, 2020-2030, USD (Million)
        • 9.4.1.1.1. Ventricular Assist Devices Market: By Application, 2020-2030, USD (Million)
      • 9.4.1.2. Japan
        • 9.4.1.2.1. Ventricular Assist Devices Market: By Type, 2020-2030, USD (Million)
        • 9.4.1.2.1. Ventricular Assist Devices Market: By Application, 2020-2030, USD (Million)
      • 9.4.1.3. India
        • 9.4.1.3.1. Ventricular Assist Devices Market: By Type, 2020-2030, USD (Million)
        • 9.4.1.3.1. Ventricular Assist Devices Market: By Application, 2020-2030, USD (Million)
      • 9.4.1.4. Australia
        • 9.4.1.4.1. Ventricular Assist Devices Market: By Type, 2020-2030, USD (Million)
        • 9.4.1.4.1. Ventricular Assist Devices Market: By Application, 2020-2030, USD (Million)
      • 9.4.1.5. South Korea
        • 9.4.1.5.1. Ventricular Assist Devices Market: By Type, 2020-2030, USD (Million)
        • 9.4.1.5.1. Ventricular Assist Devices Market: By Application, 2020-2030, USD (Million)
      • 9.4.1.6. Rest of Asia Pacific
        • 9.4.1.6.1. Ventricular Assist Devices Market: By Type, 2020-2030, USD (Million)
        • 9.4.1.6.1. Ventricular Assist Devices Market: By Application, 2020-2030, USD (Million)

10. Latin America Ventricular Assist Devices Market, 2020-2030, USD (Million)

  • 10.1. Market Overview
  • 10.2. Ventricular Assist Devices Market: By Type, 2020-2030, USD (Million)
  • 10.3. Ventricular Assist Devices Market: By Application, 2020-2030, USD (Million)
  • 10.4.Ventricular Assist Devices Market: By Region, 2020-2030, USD (Million)
    • 10.4.1.Latin America
      • 10.4.1.1. Brazil
        • 10.4.1.1.1. Ventricular Assist Devices Market: By Type, 2020-2030, USD (Million)
        • 10.4.1.1.1. Ventricular Assist Devices Market: By Application, 2020-2030, USD (Million)
      • 10.4.1.2. Mexico
        • 10.4.1.2.1. Ventricular Assist Devices Market: By Type, 2020-2030, USD (Million)
        • 10.4.1.2.1. Ventricular Assist Devices Market: By Application, 2020-2030, USD (Million)
      • 10.4.1.3. Rest of Latin America
        • 10.4.1.3.1. Ventricular Assist Devices Market: By Type, 2020-2030, USD (Million)
        • 10.4.1.3.1. Ventricular Assist Devices Market: By Application, 2020-2030, USD (Million)

11. Middle East and Africa Ventricular Assist Devices Market, 2020-2030, USD (Million)

  • 11.1. Market Overview
  • 11.2. Ventricular Assist Devices Market: By Type, 2020-2030, USD (Million)
  • 11.3. Ventricular Assist Devices Market: By Application, 2020-2030, USD (Million)
  • 11.4.Ventricular Assist Devices Market: By Region, 2020-2030, USD (Million)
    • 11.4.1.Middle East and Africa
      • 11.4.1.1. GCC
        • 11.4.1.1.1. Ventricular Assist Devices Market: By Type, 2020-2030, USD (Million)
        • 11.4.1.1.1. Ventricular Assist Devices Market: By Application, 2020-2030, USD (Million)
      • 11.4.1.2. Africa
        • 11.4.1.2.1. Ventricular Assist Devices Market: By Type, 2020-2030, USD (Million)
        • 11.4.1.2.1. Ventricular Assist Devices Market: By Application, 2020-2030, USD (Million)
      • 11.4.1.3. Rest of Middle East and Africa
        • 11.4.1.3.1. Ventricular Assist Devices Market: By Type, 2020-2030, USD (Million)
        • 11.4.1.3.1. Ventricular Assist Devices Market: By Application, 2020-2030, USD (Million)

12. Company Profile

  • 12.1. Abiomed
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Portfolio
    • 12.1.4. Strategic Initiatives
  • 12.2. Berlin Heart GmbH
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Portfolio
    • 12.2.4. Strategic Initiatives
  • 12.3. Cardiac Assist, Inc.
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Portfolio
    • 12.3.4. Strategic Initiatives
  • 12.4. HeartWare International, Inc.
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Portfolio
    • 12.4.4. Strategic Initiatives
  • 12.5. Jarvik Heart, Inc.
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Portfolio
    • 12.5.4. Strategic Initiatives
  • 12.6. Reliant Heart, Inc.
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Portfolio
    • 12.6.4. Strategic Initiatives
  • 12.7. St. Jude Medical, LLC.
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Portfolio
    • 12.7.4. Strategic Initiatives
  • 12.8. Sun Medical Technology Research Corp.
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Portfolio
    • 12.8.4. Strategic Initiatives
  • 12.9. Syncardia System, Inc.
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Portfolio
    • 12.9.4. Strategic Initiatives
  • 12.10. Thoratec Corporation
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Portfolio
    • 12.10.4. Strategic Initiatives